Graham G. Walmsley

Graham G. Walmsley is listed in filings as Director at Akero Therapeutics, Inc.. This profile follows SEC Form 4 activity through Dec 9, 2025, including purchase activity and sale activity. Recent filings connect the profile to Akero Therapeutics, Inc. (AKRO) and Olema Pharmaceuticals, Inc. (OLMA). The current snapshot covers public activity from Jun 18, 2024 to Dec 9, 2025. Reported amounts are shown as $762.5K to $475.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.